REGAIN cochlear hair cell regeneration study – opportunity to be involved
The assumption has long been that sensorineural hearing loss is irreversible because once the hair cells in the cochlea become damaged, they cannot regenerate. However, recent studies in animals with hearing loss have shown that new and functioning hair cells can be generated using a locally applied drug, called a Gamma Secretase Inhibitor. The REGAIN project tests if it is safe to use this drug in patients with hearing loss and if it improves their hearing.
The REGAIN team are looking for people aged 18-80 years with mild to moderate sensorineural hearing loss of less than 10 years duration, who are either using or have been previously offered a hearing aid.
If you are interested in taking part in the study by identifying potential participants in your clinics and providing patient information about the trial, we can help set up your department as a Patient Identification Centre.
Please contact us: